Litcius/Paper detail

PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling

Neha Dhir, Ashish Jain, Amit Raj Sharma, Ajay Prakash, Bishan Radotra, Bikash Medhi

2023Metabolic Brain Disease29 citationsDOI

Topics & Concepts

ATF4Unfolded protein responseEndoplasmic reticulumNeuroprotectionIschemiaCHOPMedicineBrain ischemiaNeurosciencePharmacologyInternal medicineCell biologyBiologyEndoplasmic Reticulum Stress and DiseaseAutophagy in Disease and TherapyRNA regulation and disease
PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling | Litcius